Prognostic impact of polypharmacy and drug interactions in patients with advanced cancer
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prognostic impact of polypharmacy and drug interactions in patients with advanced cancer
Authors
Keywords
Drug safety, Drug interactions, Breast cancer, Lung cancer, Anticancer drugs
Journal
CANCER CHEMOTHERAPY AND PHARMACOLOGY
Volume 83, Issue 4, Pages 763-774
Publisher
Springer Nature
Online
2019-01-25
DOI
10.1007/s00280-019-03783-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Drug-drug interactions in pediatric oncology patients
- (2017) T. E. Balk et al. PEDIATRIC BLOOD & CANCER
- Potential Drug-Drug and Herb-Drug Interactions in Patients With Cancer: A Prospective Study of Medication Surveillance
- (2017) Allan Ramos-Esquivel et al. Journal of Oncology Practice
- An assessment of the impact of herb-drug combinations used by cancer patients
- (2016) Saud M. Alsanad et al. BMC Complementary and Alternative Medicine
- Drug–drug interactions of cytostatics with regular medicines in lung cancer patients
- (2016) Florentine MV Rompelman et al. JOURNAL OF ONCOLOGY PHARMACY PRACTICE
- Drug–drug interactions in patients receiving tyrosine kinase inhibitors
- (2016) Kristine L Keller et al. JOURNAL OF ONCOLOGY PHARMACY PRACTICE
- The rising tide of polypharmacy and drug-drug interactions: population database analysis 1995–2010
- (2015) Bruce Guthrie et al. BMC Medicine
- A pilot study on the impact of known drug-drug interactions in cancer patients
- (2015) Silvia Ussai et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Fatal Thrombosis of a Flow Diverter due to Ibuprofen-related Antagonization of Acetylsalicylic Acid
- (2015) R. Martinez-Moreno et al. Clinical Neuroradiology
- Drug-related problems in elderly patients with cancer receiving outpatient chemotherapy
- (2015) Ting Ting Yeoh et al. Journal of Geriatric Oncology
- Potential drug–drug interactions in hospitalized patients undergoing systemic chemotherapy: a prospective cohort study
- (2015) Paula Stoll et al. International Journal of Clinical Pharmacy
- Oral epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of non-small cell lung cancer: Comparative pharmacokinetics and drug–drug interactions
- (2014) Solange Peters et al. CANCER TREATMENT REVIEWS
- Sunitinib for metastatic renal cell cancer patients: observational study highlighting the risk of important drug-drug interactions
- (2014) V. Kruse et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Drug–drug interactions with tyrosine-kinase inhibitors: a clinical perspective
- (2014) Roelof W F van Leeuwen et al. LANCET ONCOLOGY
- Adverse Drug Events: How Information Technology will Meet the Challenges of Pharmacovigilance
- (2014) S. Ussai et al. VALUE IN HEALTH
- Potential drug interactions and chemotoxicity in older patients with cancer receiving chemotherapy
- (2014) Mihaela A. Popa et al. Journal of Geriatric Oncology
- Pharmacoepidemiological study of drug–drug interactions in onco-hematological pediatric patients
- (2014) M. Angeles Fernández de Palencia Espinosa et al. International Journal of Clinical Pharmacy
- Oral Chemotherapy Food and Drug Interactions: A Comprehensive Review of the Literature
- (2014) Eve M. Segal et al. Journal of Oncology Practice
- Playing Russian Roulette With Tyrosine Kinase Inhibitors
- (2013) R Z Szmulewitz et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Characteristics of potential drug-related problems among oncology patients
- (2013) Arjan Bulsink et al. International Journal of Clinical Pharmacy
- Hepatic and Intestinal Drug Transporters: Prediction of Pharmacokinetic Effects Caused by Drug-Drug Interactions and Genetic Polymorphisms
- (2012) Kenta Yoshida et al. Annual Review of Pharmacology and Toxicology
- Interference of NSAIDs with the thrombocyte inhibitory effect of aspirin: A placebo-controlled, ex vivo, serial placebo-controlled serial crossover study
- (2012) I. L. Meek et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Updating and Validating the Charlson Comorbidity Index and Score for Risk Adjustment in Hospital Discharge Abstracts Using Data From 6 Countries
- (2011) H. Quan et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Potential drug interactions in cancer therapy: a prevalence study using an advanced screening method
- (2011) R. W. .F. van Leeuwen et al. ANNALS OF ONCOLOGY
- Inconsistent Labeling of Food Effect for Oral Agents across Therapeutic Areas: Differences between Oncology and Non-Oncology Products
- (2010) S. P. Kang et al. CLINICAL CANCER RESEARCH
- Potential drug–drug interactions between anti-cancer agents and community pharmacy dispensed drugs
- (2010) Marsha L. Voll et al. PHARMACY WORLD & SCIENCE
- Drug interactions in oncology: how common are they?
- (2009) R. P. Riechelmann et al. ANNALS OF ONCOLOGY
- Potential Drug Interactions in Cancer Patients Receiving Supportive Care Exclusively
- (2008) Rachel P. Riechelmann et al. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started